Download Medical: Supraventricular Tachycardia (including Atrial Fibrillation

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Rhetoric of health and medicine wikipedia , lookup

Patient safety wikipedia , lookup

Medical ethics wikipedia , lookup

Electronic prescribing wikipedia , lookup

List of medical mnemonics wikipedia , lookup

Transcript
Medical: Supraventricular Tachycardia (including Atrial Fibrillation) –
9914147
History
Medications: Aminophylline,
diet pills, thyroid supplements
Drugs: nicotine, cocaine, MSG
toxicity
Past medical history
History of palpitations
Syncope/near syncope
Physical
HR > 150
QRS < 0.12 seconds
Dizziness
Chest pain
Dyspnea
Poor perfusion/peripheral pulses
Differential Diagnoses
Heart disease
Sick Sinus syndrome
Myocardial infarction
Electrolyte imbalance
Exertion, pain, stress
Fever
Hypoxia
Hypovolemia or anemia
Drug effect or overdose
Hyperthyroidism
Pulmonary embolism
PEARL/S:
Stable is defined as a patient who is symptomatic with normal perfusion, normal vitals and no
alteration in mental status.
Adenosine (Adenocard®) should be administered in a proximal injection port followed by a 20
mL flush.
Metoprolol (Lopressor®) should be avoided if cocaine, methamphetamine or other
sympathomimetic use is known or suspected.
Use manufacturer recommendations for escalating energy settings.
Document all rhythm changes with monitor strips.
Adult/Medical/Updated 2015
Atrial Fibrillation
EMT
EN/A
I/P
Med
Control
Universal Care Protocol
Vascular access procedure with fluid bolus
For a stable patient who is symptomatic with a ventricular rate (≥) greater than or
equal to 150, consider metoprolol (Lopressor®) 5 mg IV, slow IV push.
May repeat every 10 minutes to a maximum of 15 mg to achieve ventricular rate of
less than or equal to 120.
* For unstable patient, consider synchronized cardioversion (total of 2 attempts)*
For patients who do not respond to cardioversion or who have recurrent tachycardia,
metoprolol (Lopressor®) 5 mg IV prior to repeated cardioversion.
Amiodarone (Cordarone®) 150 mg in 100 mL of D5W, IV piggyback over 10 minutes
Midazolam (Versed®) 2 – 5 mg IV if needed prior to synchronized cardioversion
Supraventricular Tachycardia
EMT
EN/A
Universal Care Protocol
IV/IO/Vascular Access
If patient is stable, attempt vagal maneuvers
If symptomatic, adenosine (Adenocard®) 6 mg rapid IV push, if no response,
adenosine (Adenocard®) 12 mg rapid IV push
I/P
If patient is unstable and IV access, consider adenosine (Adenocard®) 12 mg rapid IV
push or synchronized cardioversion.
If no IV access and unstable, consider synchronized cardioversion. May repeat
cardioversion for a total of 2 attempts.
If no response to cardioversion or recurrent or refractory arrhythmias, metoprolol
(Lopressor®) 5 mg slow IV push
If no response to metoprolol (Lopressor®), amiodarone (Cordarone®) 150 mg IV
Med
piggyback over 10 minutes
Control
For 3rd cardioversion attempt after metoprolol (Lopressor®) or amiodarone
(Cordarone®) has been infused.
Midazolam (Versed®) 2 – 5 mg IV if needed prior to synchronized cardioversion
Adult/Medical/Updated 2015